This analysis revealed that PTVs in 14 out of the 18 genes identified in the primary analysis remained significantly enriched in MND cases compared to controls (PSKAT-O < 2.5 × 10−6, Table 1), except for SLC44A3, ATP10A, FRAS1 and NLRP2. This evidence concerns the gene FRAS1 and mild neurocognitive disorder.